Fig. 7

CREBBP and KAT2A gene amplification in breast cancer cases with different ERα and PR status. a Bars depict the association of CREBBP and KAT2A genes amplification (AMP) across different breast cancer subtypes (Luminal B: ERα+/HER2+-high proliferation, Luminal A: ERα+/HER2+-low proliferation, Triple negative: ERα−/HER2− and HER2-overexpressed: HER2+). b, c The amplification status of CREBBP and KAT2A genes are depicted for b ERα+ (green) and ERα− (orange) samples and for c PR+ (green) and PR− (orange) samples. d The distribution of breast cancer patients who received hormonal therapy according to their CREBBP and KAT2A gene amplification status. p < 0.05 is statistically significant